20 October 2015 - The U.S. Food and Drug Administration today approved Coagadex, Coagulation Factor X (Human), for hereditary Factor X (10) deficiency. Until today’s orphan drug approval, no specific coagulation factor replacement therapy was available for patients with hereditary Factor X deficiency.

For more details, go to: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm468038.htm?source=govdelivery&utm_medium=email&utm_source=govdelivery